​

Privia Health Group (PRVA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PRVA Stock Forecast

Privia Health Group (PRVA) stock forecast, based on 22 Wall Street analysts, predicts a 12-month average price target of $31.00, with a high of $36.00 and a low of $22.00. This represents a 46.16% increase from the last price of $21.21.

$15 $20 $25 $30 $35 $40 High: $36 Avg: $31 Low: $22 Last Closed Price: $21.21

PRVA Stock Rating

Privia Health Group stock's rating consensus is Buy, based on 22 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 20 Buy (90.91%), 2 Hold (9.09%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 22 0 2 20 Strong Sell Sell Hold Buy Strong Buy

PRVA Price Target Upside V Benchmarks

TypeNameUpside
StockPrivia Health Group46.16%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Information Services Stocks 51.98%

Price Target Trends

1M3M12M
# Anlaysts-48
Avg Price Target-$32.50$30.25
Last Closing Price$21.21$21.21$21.21
Upside/Downside-53.23%42.62%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 265142--21
Mar, 265132--20
Feb, 265142--21
Jan, 264142--20
Dec, 254142--20
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 26, 2026Jack SlevinJefferies$32.00$24.9128.46%50.87%
Feb 26, 2026Jessica TassanPiper Sandler$36.00$24.9144.52%69.73%
Jan 09, 2026RBC Capital$31.00$23.1533.91%46.16%
Jan 06, 2026Wolfe Research$31.00$24.1428.42%46.16%
Nov 12, 2025Canaccord Genuity$34.00$24.3239.80%60.30%
Oct 09, 2025Barclays$22.00$24.53-10.31%3.72%
Aug 29, 2025JMP Securities$30.00$21.8137.55%41.44%
Apr 15, 2025Michael HaRobert W. Baird$26.00$24.107.88%22.58%
Feb 28, 2025JMP Securities$29.00$24.9716.14%36.73%
Feb 28, 2025Piper Sandler$40.00$24.9760.19%88.59%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 26, 2026JefferiesBuyBuyhold
Feb 26, 2026Piper SandlerOverweightOverweighthold
Jan 06, 2026CitigroupMarket OutperformMarket Outperformhold
Nov 12, 2025Canaccord GenuityBuyBuyhold
Aug 29, 2025CitigroupOutperformOutperformhold
Jan 10, 2025NeedhamBuyinitialise
Oct 10, 2024KeyBancOverweightinitialise
Aug 14, 2024RBC CapitalEqual-WeightEqual-Weighthold
Aug 08, 2024Evercore ISIOutperformOutperformhold
May 20, 2024BarclaysEqual-WeightEqual-Weighthold

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.77$-0.11$0.20$0.12$0.19---
Avg Forecast$-1.81$-0.25$0.21$0.13$0.26$0.36$0.58$0.75
High Forecast$-1.72$-0.24$0.24$0.17$0.33$0.50$0.68$0.79
Low Forecast$-1.89$-0.27$0.19$0.10$0.17$0.26$0.48$0.68
Surprise %-2.21%-56.00%-4.76%-7.69%-26.92%---

Revenue Forecast

$500M $1B $2B $2B $3B $4B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$966.22M$1.36B$1.66B$1.74B$2.12B---
Avg Forecast$917.73M$1.33B$1.64B$1.70B$1.89B$2.13B$2.52B$2.96B
High Forecast$946.87M$1.38B$1.65B$1.71B$1.99B$2.13B$2.52B$3.11B
Low Forecast$880.42M$1.26B$1.53B$1.68B$1.69B$2.13B$2.52B$2.76B
Surprise %5.28%2.33%0.85%2.33%12.34%---

Net Income Forecast

$-5B $1B $7B $13B $19B $25B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-188.23M$-8.59M$23.08M$14.38M$22.92B---
Avg Forecast$-225.92M$-31.49M$26.33M$12.82M$33.58M$47.84M$82.25M$92.89M
High Forecast$-213.98M$-29.33M$29.40M$21.71M$41.14M$62.13M$84.79M$98.98M
Low Forecast$-235.25M$-33.16M$23.27M$11.94M$21.71M$32.31M$59.85M$84.43M
Surprise %-16.68%-72.74%-12.36%12.17%68144.94%---

PRVA Forecast FAQ

Is Privia Health Group stock a buy?

Privia Health Group stock has a consensus rating of Buy, based on 22 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 20 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Privia Health Group is a favorable investment for most analysts.

What is Privia Health Group's price target?

Privia Health Group's price target, set by 22 Wall Street analysts, averages $31 over the next 12 months. The price target range spans from $22 at the low end to $36 at the high end, suggesting a potential 46.16% change from the previous closing price of $21.21.

How does Privia Health Group stock forecast compare to its benchmarks?

Privia Health Group's stock forecast shows a 46.16% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the healthcare information services stocks industry (51.98%).

What is the breakdown of analyst ratings for Privia Health Group over the past three months?

  • April 2026: 23.81% Strong Buy, 66.67% Buy, 9.52% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 25.00% Strong Buy, 65.00% Buy, 10.00% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 23.81% Strong Buy, 66.67% Buy, 9.52% Hold, 0% Sell, 0% Strong Sell.

What is Privia Health Group’s EPS forecast?

Privia Health Group's average annual EPS forecast for its fiscal year ending in December 2026 is $0.36, marking a 89.47% increase from the reported $0.19 in 2025. Estimates for the following years are $0.58 in 2027, and $0.75 in 2028.

What is Privia Health Group’s revenue forecast?

Privia Health Group's average annual revenue forecast for its fiscal year ending in December 2026 is $2.13B, reflecting a 0.40% increase from the reported $2.12B in 2025. The forecast for 2027 is $2.52B, and $2.96B for 2028.

What is Privia Health Group’s net income forecast?

Privia Health Group's net income forecast for the fiscal year ending in December 2026 stands at $47.84M, representing a -99.79% decrease from the reported $22.92B in 2025. Projections indicate $82.25M in 2027, and $92.89M in 2028.